Keyphrases
Clinical Development
100%
Personalized Cancer Therapy
100%
Neoantigen Vaccine
100%
Vaccine Platform
100%
Cancer Neoantigens
66%
Genetic Modification
16%
Neoantigen
16%
Clinical Experience
16%
Immune System
16%
PubMed
16%
Cancer Immunotherapy
16%
Synthetic Peptides
16%
Tumor Immunity
16%
Expert Opinion
16%
Mechanism of Action
16%
Amino Acid Sequence
16%
Early Phase Clinical Trials
16%
Specific Immune Response
16%
DNA Vaccine
16%
Sequencing Technology
16%
Area Cover
16%
Immunosuppressive Microenvironment
16%
Dendritic Cell Vaccine
16%
Early Clinical Exposure
16%
Neoantigen Prediction
16%
Immune Toxicity
16%
Neoantigen Identification
16%
Immunology and Microbiology
Immunotherapy
100%
Neoantigen
100%
Immune Response
8%
Autoimmunity
8%
Immunosuppressive Drug
8%
Cancer Immunotherapy
8%
Amino Acid Sequence
8%
Gene Mutation
8%
Dendritic Cell Vaccine
8%
Medline
8%
Immune System
8%
DNA Immunization
8%
Peptides
8%